Immune Regulatory Disorder clinical trials at UCSF

1 research study open to eligible people

Immune regulatory disorders are conditions where the immune system does not work properly. UCSF is studying how treating inflammation before a stem cell transplant might help people with these disorders. This research could help improve transplant outcomes for those with primary immune regulatory disorders or autoinflammatory conditions.

Showing trials for

  • Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

    open to all eligible people

    The researchers are doing this study to find out whether emapalumab or a combination of fludarabine and dexamethasone are effective in preparing people with a primary immune regulatory disorder (PIRD) and/or an autoinflammatory condition to receive a stem cell transplant. The researchers will look at how well the study treatments reduce inflammation and aid in the engraftment process (the process of donated stem cells traveling to the bone marrow, where they begin to make new immune cells. "Funding Source - FDA OOPD"

    San Francisco, California and other locations

Last updated: